Focal Hepatic Lesions: Detection and Characterization with Combination Gadolinium- and Superparamagnetic Iron Oxide–enhanced MR Imaging
- 1 September 2003
- journal article
- clinical trial
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 228 (3) , 719-726
Abstract
To compare gadolinium- and superparamagnetic iron oxide (SPIO)-enhanced magnetic resonance (MR) imaging for detection and characterization of focal hepatic lesions when different contrast agent administration sequences are used. Unenhanced, dynamic gadolinium-enhanced, and SPIO-enhanced hepatic MR images were obtained in 134 patients. SPIO-enhanced MR imaging was performed immediately after gadolinium-enhanced dynamic MR imaging in 50 patients, 1 day after gadolinium-enhanced dynamic MR imaging in 40 patients, and before gadolinium-enhanced dynamic MR imaging in 44 patients. Two radiologists independently reviewed the gadolinium image set (unenhanced and gadolinium-enhanced dynamic MR images) and the SPIO image set (unenhanced and SPIO-enhanced MR images) in random order. Lesion detection sensitivity and lesion characterization accuracy were compared by analyzing the area under the receiver operating characteristic curve (Az). Overall lesion detection accuracy for pooled data was significantly higher with the SPIO set (Az = 0.903) than with the gadolinium set (Az = 0.857) (P <.05). When hypovascular lesions were excluded, the detection rate was similar with the two sets. When hepatocellular carcinomas were excluded, the detection rate was significantly higher with the SPIO set (P <.01). Readers were more accurate in differentiating benign from malignant lesions with the gadolinium set (Az = 0.915) than with the SPIO set (Az = 0.847) (P <.01). Detection accuracy tended to be better with the images obtained after the second contrast agent was used. Hypovascular lesion detection was better with SPIO-enhanced MR images than with gadolinium-enhanced MR images. Detection and characterization of hypervascular lesions were improved with gadolinium-enhanced MR images.Keywords
This publication has 29 references indexed in Scilit:
- Detection of Malignant Hepatic TumorsAmerican Journal of Roentgenology, 2001
- Dual Contrast Enhanced Magnetic Resonance Imaging of the Liver with Superparamagnetic Iron Oxide Followed by Gadolinium for Lesion Detection and CharacterizationClinical Radiology, 2001
- Preoperative Detection of Hepatocellular CarcinomaAmerican Journal of Roentgenology, 2001
- Detection of Hepatic Lesions in Candidates for SurgeryAmerican Journal of Roentgenology, 2000
- Characterization of Focal Hepatic Lesions with Ferumoxides-Enhanced T2-Weighted MR ImagingAmerican Journal of Roentgenology, 2000
- Preoperative Detection of Malignant Hepatic TumorsAmerican Journal of Roentgenology, 2000
- Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.American Journal of Roentgenology, 1999
- Liver Imaging With Ferumoxides (Feridex??)Topics in Magnetic Resonance Imaging, 1998
- Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years.American Journal of Roentgenology, 1990
- Superparamagnetic iron oxide: pharmacokinetics and toxicityAmerican Journal of Roentgenology, 1989